Literature DB >> 19879295

Inhibition of TLR4 signaling prolongs Treg-dependent murine islet allograft survival.

N Zhang1, B Krüger, G Lal, Y Luan, A Yadav, W Zang, M Grimm, A M Waaga-Gasser, B Murphy, J S Bromberg, B Schröppel.   

Abstract

Toll-like receptors (TLRs) provide an important link between innate and adaptive immune system. We hypothesized that the recognition of endogenous TLR4 ligands is occurring at the time of transplantation, and these innate signals drive the inflammation and affect alloimmune responses. We confirmed that early after transplantation of allogenic islets, transcripts for TLR4 as well as potential ligands were released or up-regulated. In an allogenic islet transplantation model, genetic disruption of TLR4 on donor islets had no effect on allograft survival, whereas TLR4 deficiency in recipients lead to prolonged graft survival. Low dose rapamycin-treatment of TLR4(-/-) recipients induced permanent engraftment of 45% islet graft (p=0.005) compared to WT recipients. This prolonged graft survival was dependent on the presence of CD4(+)CD25(+)Foxp3(+) Treg. Naïve CD4(+)CD25(-) T cells cultured with the TLR4 ligand lipopolysaccharide showed enhanced IL-4, IL-6, IL-17, IFN gamma secretion and inhibited TGFbeta induced Foxp3(+)Treg generation. Thus, inhibition of recipient TLR4 activation at the time of transplantation decreases proinflammatory signals and allows Treg generation. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19879295      PMCID: PMC2808455          DOI: 10.1016/j.imlet.2009.10.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  38 in total

1.  Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.

Authors:  Bernd Schröppel; Nan Zhang; Peng Chen; Weiping Zang; Dongmei Chen; Kelly L Hudkins; William A Kuziel; Randall Sung; Jonathan S Bromberg; Barbara Murphy
Journal:  J Am Soc Nephrol       Date:  2004-07       Impact factor: 10.121

2.  TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.

Authors:  Thomas B Thornley; Michael A Brehm; Thomas G Markees; Leonard D Shultz; John P Mordes; Raymond M Welsh; Aldo A Rossini; Dale L Greiner
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

3.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product.

Authors:  K Hoshino; O Takeuchi; T Kawai; H Sanjo; T Ogawa; Y Takeda; K Takeda; S Akira
Journal:  J Immunol       Date:  1999-04-01       Impact factor: 5.422

4.  Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.

Authors:  Kook-Hwan Oh; Jae Young Kim; Donghee Kim; Eun Mi Lee; Ha Young Oh; Jeong-Sun Seo; Jin Suk Han; Suhnggwon Kim; Jung Sang Lee; Curie Ahn
Journal:  Transpl Immunol       Date:  2004-12       Impact factor: 1.708

5.  The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

Authors:  Yanyan Qu; Baojun Zhang; Liang Zhao; Guangwei Liu; Haixia Ma; Enyu Rao; Chun Zeng; Yong Zhao
Journal:  Transpl Immunol       Date:  2007-01-24       Impact factor: 1.708

6.  Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance.

Authors:  Yiping Yang; Ching-Tai Huang; Xiaopei Huang; Drew M Pardoll
Journal:  Nat Immunol       Date:  2004-04-04       Impact factor: 25.606

7.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

8.  Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor.

Authors:  Iris Lee; Liqing Wang; Andrew D Wells; Martin E Dorf; Engin Ozkaynak; Wayne W Hancock
Journal:  J Exp Med       Date:  2005-04-04       Impact factor: 14.307

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

View more
  12 in total

1.  Physiologic Doses of Bilirubin Contribute to Tolerance of Islet Transplants by Suppressing the Innate Immune Response.

Authors:  Christopher A Adin; Zachary C VanGundy; Tracey L Papenfuss; Feng Xu; Mostafa Ghanem; Jonathan Lakey; Gregg A Hadley
Journal:  Cell Transplant       Date:  2016-07-07       Impact factor: 4.064

2.  Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation.

Authors:  Bernd Krüger; Na Yin; Nan Zhang; Anju Yadav; William Coward; Girdhari Lal; Weiping Zang; Peter S Heeger; Jonathan S Bromberg; Barbara Murphy; Bernd Schröppel
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

Review 3.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

Review 4.  Innate immunity and organ transplantation: focus on lung transplantation.

Authors:  Daniel Kreisel; Daniel R Goldstein
Journal:  Transpl Int       Date:  2012-08-21       Impact factor: 3.782

Review 5.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

6.  Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.

Authors:  Preeti Chhabra; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-20

7.  Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells.

Authors:  Timothy R Crother; Nicolas W J Schröder; Justin Karlin; Shuang Chen; Kenichi Shimada; Anatoly Slepenkin; Randa Alsabeh; Ellena Peterson; Moshe Arditi
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

8.  Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation.

Authors:  Cyrus Jahansouz; Cameron Jahansouz; Sean C Kumer; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-15

Review 9.  The innate immune system and transplantation.

Authors:  Conrad A Farrar; Jerzy W Kupiec-Weglinski; Steven H Sacks
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

10.  Regulatory and Effector Helper T-Cell Profile after Nerve Xenografting in the Toll-Like Receptor-Deficient Mice.

Authors:  Cheng-Shyuan Rau; Ming-Wei Lin; Shao-Chun Wu; Yi-Chan Wu; Tsu-Hsiang Lu; Siou-Ling Tzeng; Yi-Chun Chen; Chia-Jung Wu; Ching-Hua Hsieh
Journal:  Int J Med Sci       Date:  2015-08-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.